Zimmer Biomet to Acquire Monogram Technologies in $177 Million Deal, Expanding Orthopedic Robotics Portfolio

Reuters
14 Jul
Zimmer Biomet to Acquire Monogram Technologies in $177 Million Deal, Expanding Orthopedic Robotics Portfolio

Zimmer Biomet Holdings, Inc. has announced a definitive agreement to acquire Monogram Technologies Inc., an orthopedic robotics company, for an upfront payment of $4.04 per share in cash, valuing the equity at approximately $177 million. The acquisition, which has been unanimously approved by the boards of both companies, aims to expand Zimmer Biomet's portfolio with Monogram's autonomous surgical solutions. The deal is expected to be neutral to adjusted earnings per share between 2025 and 2027 and contribute to revenue growth starting in 2027. Monogram stockholders will also receive a contingent value right, potentially offering up to $12.37 per share if certain milestones are met by 2030.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Monogram Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9493838-en) on July 14, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10